A new study, published in The Journal of the American Medical Association this month, has found that high doses of three B vitamins: B6, B12, and folate, do not slow the progression of Alzheimer’s disease.

Researchers from the Department of Neurosciences at the University of California randomly assigned 340 participants suffering from mild Alzheimer’s disease into a high dose group and a control group.

Read The Full Post »»

Statins, a class of drugs used to lower cholesterol in people at risk of heart disease, may also be effective in preventing Alzheimer’s disease and other dementias according to a new report published in the July 29 edition of the peer-reviewed medical journal Neurology.

The research comes out of the University of Michigan and involved the study of 1,674 elderly Mexican-Americans from Sacramento, California. At the beginning of the 5-year study none of the participants showed signs of dementia or cognitive impairment.

Read The Full Post »»

People who regularly take non-steroidal anti-inflammatory drugs (NSAID’s) for more than five years are significantly less likely to develop Alzheimer’s disease according to a study published this month in the journal Neurology.

The study found that certain NSAID’s, in particular ibuprofen, cut the risk of Alzheimer’s disease by almost 50% however other NSAID’s including aspirin and COX-2 inhibitors such as celecoxib did not have an effect on Alzheimer’s disease.

Read The Full Post »»

A new study, presented at the annual Academy of Neurology meeting in Chicago this month suggests that Vitamin E, particularly when combined with a cholinesterase inhibitor, extends the lifetimes of Alzheimer’s sufferers by a significant amount.

The researchers analyzed the survival rates of 847 people who had been diagnosed with Alzheimer’s disease.The majority of the patients in the study were women and the average age of participants was 74 years.

Read The Full Post »»

A recent United States study has documented a case where an arthritis drug called Etanercept, (also known as Enbrel), caused a rapid improvement in the cognitive function of a patient with Alzheimer’s disease with minutes of the drug being injected into the patients spine.

According to the authors of the study, the patient initially appeared agitated and could not recall the state he lived in but just ten minutes after treatment, he was more relaxed, attentive, and could correctly name the state.

Read The Full Post »»